Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.9500 (-3.17%) ($7.8750 - $7.9500) on Wed. Jun. 14, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.75% (three month average) | RSI | 45 | Latest Price | $7.9500(-3.17%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -2% a day on average for past five trading days. | Weekly Trend | BCRX advances 1.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) BND(25%) ARKG(22%) CEMB(19%) BNDX(18%) BWX(18%) | Factors Impacting BCRX price | BCRX will decline at least -1.375% in a week (0% probabilities). BLOK(7%) ARKK(9%) ACES(9%) BOTZ(11%) BWX(18%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.375% (StdDev 2.75%) | Hourly BBV | -1.4 () | Intraday Trend | 0% | | | |
|
Resistance Level | $8.37 | 5 Day Moving Average | $8.37(-5.02%) | 10 Day Moving Average | $8.42(-5.58%) | 20 Day Moving Average | $8.37(-5.02%) | To recent high | -10.2% | To recent low | 7.8% | Market Cap | $1.403b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |